ACCESS Consortium: Points to consider for strain changes in authorised COVID-19 vaccines in an ongoing SARS-CoV2 pandemic

This Points to Consider document lays out a regulatory approach for updating authorised coronavirus vaccines should mutations at any time make them less efficacious due to insufficient cross-reactivity.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-06-30

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data